The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages) View the PDF document
Table of Contents
View the documentAuthors
View the documentCountry Research Team Leaders
View the documentLaboratory Support
View the documentAcknowledgements
View the documentAcronyms
View the documentExecutive summary
View the document1. Background
Open this folder and view contents2. Methodology
View the document3. Results
Close this folder4. Discussion
View the document4.1 Is there a problem?
View the document4.2 What is the magnitude of the problem?
View the document4.3 Is the problem limited to a particular distribution level?
View the document4.4 Is the problem limited to imported or domestic products?
View the document4.5 Limitations of the methodology
Open this folder and view contents5. Conclusions and recommendations
View the documentReferences
Open this folder and view contentsTables
Open this folder and view contentsAnnexes
View the documentOther documents in the EDM Research Series
View the documentEDM Research Series No. 30
 

4.4 Is the problem limited to imported or domestic products?

No significant trend was noted in comparing local versus foreign manufacturers, as shown in Table III. There were failures of 56% (27/48) amongst locally made products, compared to 47.2% (17/36) for foreign products for CQT active ingredient content, and 28% (7/25) versus 13% (3/23) CQS active ingredient content. Further investigation of this phenomenon will be important since it is easier for national drug regulatory authorities to act and correct problems that involve domestic manufacturers.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018